期刊文献+

短链脂肪酸在肠道中的生理作用 被引量:41

Physiological function of short-chain fatty acids in the intestine
下载PDF
导出
摘要 越来越多的证据显示,短链脂肪酸对肠道的能量供应、肠黏膜屏障的维持、肠道高敏感和肠道动力的调节、免疫调节及抗肿瘤效应等有重要作用。进一步明确短链脂肪酸的生理作用及其与肠道相关疾病的关联及其内在机制,对肠道疾病的预防与治疗有重要意义。该文就短链脂肪酸在肠道中的生理作用作一综述。 More and more evidence shows that short-chain fatty acids play an important role in the intestinal energy supply,the maintaining of intestinal mucosal barrier,the regulation of intestinal hypersensitivity and motility,the immune regulation and anti-tumor effect.Clarifying the relationship between the physiological function of short-chain fatty acids and some intestinal diseases as well as the related mechanisms is significant for the prevention and treatment of these intestinal diseases.The physiological function of short-chain fatty acids in the intestine is reviewed in this paper.
作者 蒙丹丽 梁列新 宋怀宇 MENG Dan-li;LIANG Lie-xin;SONG Huai-yu(Guangxi Medical University,Nanning 530021,China)
出处 《中国临床新医学》 2018年第2期198-202,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西卫生医疗适宜技术研究与开发项目(编号:S201313-04) 广西卫计委科研课题(编号:Z2004002)
关键词 短链脂肪酸 肠道 生理作用 检测方法 Short-chain fatty acids Intestine Physiological function Detection methods
  • 相关文献

二级参考文献19

  • 1Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997; 112:1714-1743.
  • 2Lacy BE, Yu S. Tegaserod:a new 5-HT4 agonist. J Clin Gastroenterol 2002; 34:27-33.
  • 3Lu Y, Westlund KN. Effects of baclofen on colon inflammation-induced Fos, CGRP and SP expresson in spinal cord and brainstem. Brain Res 2001; 889:118-130.
  • 4Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109:40-52.
  • 5Muller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Ruegg P. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001: 15:1655-1666.
  • 6Novick J, Miner P, Krause R, Glebas K, Bliesath H, Ligozio G,Ruegg P, Lefkowitz M. A randomized double-blind, placebocontrolled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16:1877-1888.
  • 7Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhasira D.Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther 2003; 17:577-585.
  • 8Traub RJ, Pechman P, Iadarola MJ, Gebhart GF. Fos-like proteins in the lumbosacral spinal cord following noxious and nonnoxious colorectal distention in the rat. Pain 1992; 49:393-403.
  • 9Traub RJ, Stitt S, Gebhart GF. Attenuation of c-Fos expression in the rat lumbosacral spinal cord by morphine or tramadol following noxious colorectal distention. Brain Res 1995; 701:175-182.
  • 10Traub RJ, Murphy A. Colonic inflammation induces fos expression in the thoracolumbar spinal cord increasing activity in the spinoparabrachial pathway. Pain 2002; 95:93-102.

共引文献15

同被引文献423

引证文献41

二级引证文献273

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部